Chronic micro-inflammatory conditions in MetS involve an increase in immune mediators such as interleukin (IL)-6, IL-1β, and tumor necrosis factor (TNF)-α, and this can contribute to behavioral changes [6]. Here, IL6 is linked to metabolic syndrome.